Indian Pantoprazole Exporters: Complete Supplier Ranking with Market Share — 744 Manufacturers (2026) — TransData Nexus

Q: Who is the largest pantoprazole supplier from India?

MYLAN LABORATORIES LIMITED is the largest pantoprazole exporter from India with a 69.2% market share and export value of $926.3M.

Q: How many pantoprazole suppliers are there in India?

There are 744 active pantoprazole exporters in India, collectively shipping $1.3B worth of pantoprazole across 11,610 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top pantoprazole suppliers from India?

The top 5 pantoprazole suppliers from India — MYLAN LABORATORIES LIMITED, AUROBINDO PHARMA LTD, EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, TORRENT PHARMACEUTICALS LTD — together control 87.9% of total pantoprazole export value from India.

Suresh Sormare

Pantoprazole

India Pharmaceutical Trade Intelligence

$1.3B744 Suppliers154 CountriesHS 30049039

ExportsIndia → UNITED STATES68.3%India → MALTA12.6%

ImportsGERMANY → India$152.4K BRAZIL → India$68.7K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Pantoprazole Suppliers from India (2026) — 744 Exporters, $1.3B Market | TransData Nexus | TransData Nexus

Who Exports Pantoprazole from India — 744 Suppliers Behind a $1.3B Market

India's pantoprazole export market is supplied by 744 active exporters who collectively shipped $1.3B across 11,610 shipments. MYLAN LABORATORIES LIMITED leads with a 69.2% market share, followed by AUROBINDO PHARMA LTD and EUGIA PHARMA SPECIALITIES LIMITED. The top 5 suppliers together control 87.9% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published May 2026

India's Top Pantoprazole Suppliers & Exporters — 744 manufacturers, $1.3B export market, top destinations and formulations — Pantoprazole supplier data — 744 exporters · $1.3B market · 11,610 shipmentsTransData Nexus · Indian Customs Data

Top Pantoprazole Exporters from India — Ranked by Export Value

MYLAN LABORATORIES LIMITED is the leading pantoprazole exporter from India, holding a 69.2% share of the $1.3B market across 11,610 shipments from 744 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, AUROBINDO PHARMA LTD, EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, TORRENT PHARMACEUTICALS LTD — collectively control 87.9% of total export value, indicating a highly concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (69.2%), AUROBINDO PHARMA LTD (12.5%), EUGIA PHARMA SPECIALITIES LIMITED (2.4%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (2.3%), TORRENT PHARMACEUTICALS LTD (1.5%).

Top Pantoprazole Exporters from India

Ranked by export value · 744 active suppliers · Indian Customs (DGFT) data

May 2026

Top Pantoprazole Exporters from India — Ranked by Export Value. 744 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Pantoprazole — Export Intelligence Video

Visual overview of India's pantoprazole supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's pantoprazole pharmaceutical supplier landscape — $1.3B in total trade, 744 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Pantoprazole exporters

Certification and compliance status for top Pantoprazole suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Aurobindo Pharma Limited	Approved	Yes	Yes	164	Received FDA approval for Vancomycin Hydrochloride for Injection in August 2023.
Eugia Pharma Specialities Limited	Approved	Yes	Yes	164	Wholly owned subsidiary of Aurobindo Pharma; received FDA approval for Vancomyci
Mylan Laboratories Limited	Approved	Yes	Yes	Multiple	Merged with Upjohn to form Viatris in November 2020.
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	Multiple	Received FDA approval for multiple generic drugs; details available on FDA websi
Torrent Pharmaceuticals Limited	Approved	Yes	Yes	Multiple	Received Establishment Inspection Report from US FDA for Dahej facility in 2023.
Lincoln Pharmaceuticals Limited	Not Listed	Yes	Yes	Not Listed	Received EU GMP certification for Khatraj facility in May 2020.
Cipla Limited	Approved	Yes	Yes	Multiple	Received FDA approval for multiple generic drugs; details available on FDA websi
Dr. Reddy's Laboratories Ltd	Approved	Yes	Yes	Multiple	Received FDA approval for multiple generic drugs; details available on FDA websi

TransData Nexus reviewed the regulatory standing of 8 leading Pantoprazole exporters from India. 7 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Pantoprazole sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for the production of Active Pharmaceutical Ingredients (APIs). Companies like Mylan Laboratories Limited, which accounts for 69.2% of Pantoprazole exports, have significant operations in this region. The city's infrastructure supports large-scale API manufacturing, ensuring a steady supply of high-quality raw materials essential for Pantoprazole production.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara belt in Gujarat is renowned for its expertise in pharmaceutical formulations. Aurobindo Pharma Ltd., contributing 12.5% to Pantoprazole exports, has a notable presence here. This cluster excels in converting APIs into finished dosage forms, leveraging advanced manufacturing facilities and a skilled workforce to produce Pantoprazole tablets and injectables that meet international quality standards.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad region serves as a critical export gateway for pharmaceutical products. Companies such as Sun Pharmaceutical Industries Limited, responsible for 2.3% of Pantoprazole exports, operate extensively in this area. Proximity to major ports facilitates efficient global distribution, particularly to key markets like the United States, which receives 68.3% of India's Pantoprazole exports.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Pantoprazole exporters from India

January 2024

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires remaining stake in Taro Pharmaceuticals

Sun Pharma entered into a definitive merger agreement to acquire all outstanding shares of Taro Pharmaceuticals for $347.73 million, consolidating its ownership. - IMPACT: This acquisition is expected to enhance Sun Pharma's product portfolio, potentially increasing Pantoprazole exports.

Impact: This acquisition is expected to enhance Sun Pharma's product portfolio, potentially increasing Pantoprazole exports.

March 2025

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Sun Pharma acquired Checkpoint Therapeutics, a company specializing in immunotherapy and targeted oncology treatments, for $355 million. - IMPACT: This acquisition may diversify Sun Pharma's product offerings, with potential implications for Pantoprazole export strategies.

Impact: This acquisition may diversify Sun Pharma's product offerings, with potential implications for Pantoprazole export strategies.

September 2024

Common Questions — Pantoprazole Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which pantoprazole supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 661 recorded shipments worth $926.3M. AUROBINDO PHARMA LTD (1,356 shipments) and EUGIA PHARMA SPECIALITIES LIMITED (308 shipments) are also established high-volume exporters.

Q How many pantoprazole manufacturers are there in India?

India has 744 active pantoprazole exporters with a combined export market of $1.3B across 11,610 shipments to 154 countries. The top 5 suppliers hold 87.9% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for pantoprazole from India?

Average FOB unit price: $3.77 per unit, ranging from $0.00 to $4449.94. Average shipment value: $115.3K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Pantoprazole

Pantoprazole

Who Exports Pantoprazole from India — 744 Suppliers Behind a $1.3B Market

Top Pantoprazole Exporters from India — Ranked by Export Value

Top Pantoprazole Exporters from India

Related Analysis

Need Details?

Pantoprazole — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Sun Pharmaceutical Industries Limited — Sun Pharma acquires remaining stake in Taro Pharmaceuticals

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Common Questions — Pantoprazole Suppliers from India

Q Which pantoprazole supplier from India is the most reliable for bulk orders?

Q How many pantoprazole manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for pantoprazole from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Sun Pharmaceutical Industries Limited — Sun Pharma addresses counterfeit drug allegations

Analysis Methodology